Schizophrenia News and Research

Latest Schizophrenia News and Research

BG-12 effective for relapsing–remitting multiple sclerosis

Results of the CONFIRM and DEFINE studies suggest that dimethyl fumarate should be considered as an oral treatment for patients with relapsing–remitting multiple sclerosis.

24 Sep 2012

BioLineRx receives U.S. patent allowance for BL-1020 to treat schizophrenia

BioLineRx, a biopharmaceutical development company, announced today that a Notice of Allowance has been received from the United States Patent and Trademark Office (USPTO) claiming the crystalline form of BL-1020, a first-in-class orally available treatment for schizophrenia.

24 Sep 2012

Researchers solve mystery of radial glial cells

Researchers at Cold Spring Harbor Laboratory (CSHL) have solved an important piece of one of neuroscience's outstanding puzzles: how progenitor cells in the developing mammalian brain reproduce themselves while also giving birth to neurons that will populate the emerging cerebral cortex, the seat of cognition and executive function in the mature brain.

24 Sep 2012

Prevalence of sexual violence against mental health patients ‘alarming’

Around a fifth of patients with mental illnesses report being the victims of sexual violence, results from a Brazilian study show.

21 Sep 2012

First extensive analysis of Allen Human Brain Atlas

Scientists at the Allen Institute for Brain Science reported in the latest issue of the journal Nature that human brains share a consistent genetic blueprint and possess enormous biochemical complexity. The findings stem from the first deep and large-scale analysis of the vast data set publicly available in the Allen Human Brain Atlas.

21 Sep 2012

Social anxiety common in remitted schizophrenia patients

Social anxiety is common in schizophrenia patients who are in remission and is associated with reduced quality of life, Japanese study results show.

20 Sep 2012

Close monitoring could give early warning of MS disease course

Patients with multiple sclerosis who have breakthrough disease activity early in the course of treatment with interferon beta-1a are at high risk for severe worsening and poor long-term outcomes, research shows.

20 Sep 2012

Molecular disruptions in granule cells cause epileptic seizures in mice

Scientists have discovered the first direct evidence that a biological mechanism long suspected in epilepsy is capable of triggering brain seizures – opening the door for studies to seek improved treatments or even preventative therapies.

20 Sep 2012

Alexithymia linked to white matter integrity in schizophrenia

Increased levels of alexithymia among patients with schizophrenia are associated with reductions in white matter integrity in specific regions of the corpus callosum, researchers report.

19 Sep 2012

Mood disorder, anxiety risk elevated in children with mood disordered parents

Children with a parental history of bipolar disorder or major depressive disorder are at increased risk for any mood or anxiety disorder, research shows.

19 Sep 2012

CAPE effective for detecting patients at ultra-high risk for psychosis

The Community Assessment of Psychic Experience questionnaire is an effective instrument for identifying individuals at ultra-high risk for psychosis, researchers report.

18 Sep 2012

Pertussis immunity wanes in the 5 years after DTaP vaccination

The risk for pertussis infection in children who receive the combined diphtheria, tetanus, and acellular pertussis vaccine increases by an average of 42% per year after the last dose, a US study shows.

17 Sep 2012

Refinements in gene therapy prove beneficial for ‘bubble babies’

Results from a long-term study published in Blood show that adding a low dose of chemotherapy prior to gene therapy can help improve outcomes in children with adenosine deaminase-deficient severe combined immunodeficiency.

17 Sep 2012

Mental health professionals may benefit from simple tool to accurately make risk assessments

Mental health professionals, who often are tasked with evaluating and managing the risk of violence by their patients, may benefit from a simple tool to more accurately make a risk assessment, according to a recent study conducted at the University of California, San Francisco.

15 Sep 2012

Severe egg allergy treatment shows promise

Specific oral tolerance induction with raw hen’s egg can reduce the severity of egg allergy in affected children, show study findings.

14 Sep 2012

Childhood abuse linked to thalamus size in violent mental health patients

Childhood psychosocial deprivation is associated with significantly reduced thalamic volume among violent individuals with antisocial personality disorder or schizophrenia, researchers report.

14 Sep 2012

Kynurenic acid levels reduced in suicide attempters with schizophrenia

Cerebrospinal fluid concentrations of kynurenic acid are significantly lower in schizophrenia-spectrum patients with a history of suicide attempts than in those without, researchers report.

13 Sep 2012

Transcept completes enrollment in TO-2061 Phase 2 trial for obsessive compulsive disorder

Transcept Pharmaceuticals, Inc. today announced that it has completed enrollment in its Phase 2 clinical trial evaluating TO-2061 added as adjunctive therapy for patients with obsessive compulsive disorder (OCD) who have not adequately responded to first-line treatment with an approved OCD medication.

12 Sep 2012

Many pediatric respiratory hospitalizations unnecessary

Study findings suggest that a large number of pediatric hospitalizations, particularly those of a respiratory nature, could be prevented.

11 Sep 2012

Plasma biomarker predicts rheumatoid arthritis onset

Healthy individuals with high levels of immunoglobulin G rheumatoid factor have a significantly increased risk for developing rheumatoid arthritis, suggests population-based research published in the BMJ.

10 Sep 2012